COVID-19 vaccines for high risk and immunocompromised patients

The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat...

Full description

Saved in:
Bibliographic Details
Published inMethods in microbiology Vol. 50; pp. 269 - 279
Main Authors Pavia, Charles S, Plummer, Maria M
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 2022
Subjects
COVID-19 vaccines
Obesity
SARS-CoV-2
AIDS patients
HIV
Risk groups
Diabetes
Vaccines
Immunocompromised patients
Online AccessGet full text

Cover

More Information
Summary:The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat more effectively, as many people as possible need to be vaccinated, especially for high-risk groups having co-morbid conditions such as diabetes, obesity and old age, and possibly those with various forms of immunodeficiencies, such as HIV/AIDS. This chapter focuses primarily on some of the basic biomedical aspects on vaccine design and use, and any possible concerns that need to be considered in getting people in the high-risk category vaccinated and monitored thereafter for their continuous health and well-being.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0580-9517
0580-9517
DOI:10.1016/bs.mim.2021.11.001